<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Flip News — mckesson news</title>
    <link>https://flipnews.co.uk/topics/mckesson/</link>
    <description>The latest Flip News stories on mckesson.</description>
    <language>en-GB</language>
    <lastBuildDate>Tue, 06 Oct 2026 18:01:03 GMT</lastBuildDate>
    <atom:link href="https://flipnews.co.uk/topics/mckesson/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>McKesson and CD&amp;R agree $5.8bn deal for infusion therapy firm Option Care Health</title>
      <link>https://flipnews.co.uk/business/mckesson-cdr-option-care-health-58bn/</link>
      <guid isPermaLink="true">https://flipnews.co.uk/business/mckesson-cdr-option-care-health-58bn/</guid>
      <pubDate>Tue, 06 Oct 2026 00:00:00 GMT</pubDate>
      <description>Drug distributor McKesson and private equity firm Clayton Dubilier &amp; Rice have agreed to buy infusion therapy provider Option Care Health for about $5.8bn including debt, at $32.05 a share — a 37.1% premium.</description>
      <author>James Calloway</author>
      <category>mckesson</category>
      <category>healthcare</category>
      <category>private-equity</category>
      <category>acquisitions</category>
      <source url="https://www.reuters.com/legal/transactional/mckesson-cdr-buy-infusion-therapy-provider-option-care-health-58-billion-deal-2026-10-06/">Reuters</source>
    </item>
  </channel>
</rss>
